Principal Financial Group Inc Novartis Ag Transaction History

Principal Financial Group Inc

  • $162 Billion
  • Q1 2024

A detailed history of Principal Financial Group Inc transactions in Novartis Ag stock. As of the latest transaction made, Principal Financial Group Inc holds 2,523,334 shares of NVS stock, worth $260 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,523,334
Previous 2,508,648 0.59%
Holding current value
$260 Million
Previous $253 Million 3.64%
% of portfolio
0.15%
Previous 0.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$95.27 - $108.47 $1.4 Million - $1.59 Million
14,686 Added 0.59%
2,523,334 $244 Million
Q4 2023

Feb 07, 2024
SELL
$92.27 - $101.54 $2.83 Million - $3.11 Million
-30,617 Reduced 1.21%
2,508,648 $253 Million
Q3 2023

Nov 02, 2023
BUY
$94.73 - $105.13 $4.87 Million - $5.4 Million
51,391 Added 2.07%
2,539,265 $259 Million
Q2 2023

Aug 07, 2023
SELL
$92.52 - $104.91 $22.4 Million - $25.4 Million
-242,473 Reduced 8.88%
2,487,874 $251 Million
Q1 2023

May 09, 2023
BUY
$80.03 - $92.81 $21.2 Million - $24.5 Million
264,310 Added 10.72%
2,730,347 $251 Million
Q4 2022

Feb 09, 2023
BUY
$75.55 - $92.52 $589,743 - $722,211
7,806 Added 0.32%
2,466,037 $224 Million
Q3 2022

Nov 09, 2022
BUY
$74.61 - $87.26 $14.2 Million - $16.6 Million
189,855 Added 8.37%
2,458,231 $187 Million
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $1.99 Million - $2.32 Million
-24,731 Reduced 1.08%
2,268,376 $192 Million
Q1 2022

May 09, 2022
BUY
$80.11 - $90.62 $1.19 Million - $1.35 Million
14,914 Added 0.65%
2,293,107 $201 Million
Q4 2021

Feb 09, 2022
BUY
$79.7 - $88.13 $16.7 Million - $18.5 Million
209,629 Added 10.13%
2,278,193 $199 Million
Q3 2021

Nov 09, 2021
BUY
$81.78 - $95.14 $32.8 Million - $38.2 Million
401,585 Added 24.09%
2,068,564 $169 Million
Q2 2021

Aug 10, 2021
SELL
$85.24 - $94.15 $1.71 Million - $1.89 Million
-20,061 Reduced 1.19%
1,666,979 $152 Million
Q1 2021

May 10, 2021
BUY
$83.5 - $98.47 $1.07 Million - $1.27 Million
12,864 Added 0.77%
1,687,040 $144 Million
Q4 2020

Feb 23, 2021
SELL
$78.07 - $94.43 $780 - $944
-10 Reduced -0.0%
1,674,176 $158 Million
Q4 2020

Feb 08, 2021
BUY
$78.07 - $94.43 $10.3 Million - $12.5 Million
132,070 Added 8.56%
1,674,186 $158 Million
Q3 2020

Nov 06, 2020
BUY
$82.14 - $91.0 $5.31 Million - $5.89 Million
64,683 Added 4.38%
1,542,116 $134 Million
Q2 2020

Aug 05, 2020
BUY
$80.93 - $91.1 $3 Million - $3.37 Million
37,010 Added 2.57%
1,477,433 $129 Million
Q1 2020

May 12, 2020
SELL
$70.67 - $99.01 $175,614 - $246,039
-2,485 Reduced 0.17%
1,440,423 $119 Million
Q4 2019

Feb 05, 2020
BUY
$84.35 - $95.37 $6.34 Million - $7.17 Million
75,130 Added 5.49%
1,442,908 $137 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $1.38 Million - $1.53 Million
16,184 Added 1.2%
1,367,778 $119 Million
Q2 2019

Aug 12, 2019
BUY
$75.4 - $92.8 $15.2 Million - $18.7 Million
201,783 Added 17.55%
1,351,594 $123 Million
Q1 2019

May 10, 2019
BUY
$75.32 - $86.15 $73,512 - $84,082
976 Added 0.08%
1,149,811 $111 Million
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $5.81 Million - $6.47 Million
78,837 Added 7.37%
1,148,835 $98.6 Million
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $33,536 - $38,792
-501 Reduced 0.05%
1,069,998 $92.2 Million
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $2.78 Million - $3.14 Million
42,864 Added 4.17%
1,070,499 $0
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $487,450 - $582,738
-6,925 Reduced 0.67%
1,027,635 $83.1 Million
Q4 2017

Feb 13, 2018
BUY
$72.33 - $77.64 $3.67 Million - $3.94 Million
50,698 Added 5.15%
1,034,560 $86.9 Million
Q3 2017

Nov 02, 2017
BUY
$74.14 - $77.27 $72.9 Million - $76 Million
983,862
983,862 $84.5 Million

Others Institutions Holding NVS

# of Institutions
1,342
Shares Held
140M
Call Options Held
1.15M
Put Options Held
866K
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email